-
AIR and MART therapy in the context of the new asthma guideline
This is the second webinar in the PCRS Maintenance and Reliever Therapy (MART) in asthma campaign. It will provide information on anti-inflammatory reliever (AIR) and MART treatment options in the context of the BTS/NICE/SIGN asthma guideline 2024 and associated implementation guidance.
The webinar will be held on Friday 9 May 2025 at 19:00 for 45 minutes. Chaired by Katherine Hickman (our PCRS Executive Chair), she and guest speakers, Deborah Leese and Marieke Strange, will focus on:
- What AIR and MART are
- The role they play in the new BTS/NICE/SIGN asthma guidance, and
- The effective implementation of AIR and MART treatment regimes.
Particular attention will be paid to the implementation of these regimes in patients who are newly diagnosed, new to these regimes and/or have uncontrolled asthma.
We are grateful to Orion Pharma (UK) Ltd for sponsoring PCRS in developing resources for the Maintenance and Reliever Therapy (MART) in asthma project. The sponsor has had no input into the resources or webinar content.
Speakers
-
Katherine Hickman
Katherine qualified from Leeds University in 2000. She originally did a Medicine Rotation acquiring her MRCP before settling into General Practice. She is a GP Partner in Bradford. Katherine is the Respiratory Lead for West Yorkshire ICB, Primary Care Clinical Lead for the National Respiratory Audit Programme (NRAP), and Chair of PCRS. Outside of work she enjoys cooking, baking, yoga, and outdoor swimming and has recently rediscovered her love for singing and joined a choir. -
Deborah Leese
Deborah qualified as a pharmacist in 2000 with a first-class degree. She has had a varied career starting in community pharmacy, moving on to regional and national training roles and then into primary care in 2009 as a clinical pharmacist for NHS Sheffield.
In 2016 Deborah qualified as a pharmacist independent prescriber and was appointed respiratory lead pharmacist for Sheffield CCG and now for South Yorkshire ICB (Sheffield) Deborah has led on many pieces of respiratory work including guideline and formulary development. She has also developed many initiatives for inhaler optimisation for the city as well as educational sessions. Deborah is also currently Co-Clinical Lead for Children and Young Peoples Asthma for South Yorkshire, Clinical Lead for SABA reduction in South Yorkshire, Chair of the South Yorkshire Sustainable Respiratory Group and a committee member for the South Yorkshire Respiratory Interest Group.
Deborah is Vice Chair of the PCRS Service Development Committee, a member of the Policy Forum and is a core member of the Asthma Right Care team. She has contributed to various PCRS documents including Asthma Guidelines in Practice – A PCRS consensus. She has a passion for respiratory care and is focussed at putting the patient at the centre of care. -
Marieke Strange
After 5 years working in intensive care, Marieke switched to primary care and never looked back. Marieke is passionate about respiratory and is involved with local guidelines and processes. They are a Respiratory Champion, part of the PCRS Conference Committee and are most proud of (re) launching BRIG (BNSSG Respiratory Interest Group). The group meets monthly and discusses anything respiratory related; case scenarios, difficult cases, a general moan about things, what ever you like! This is all with the aim to offer more support to Practice nurses with a respiratory interest as it is often a puzzle to get things right, least of all diagnostics!
On Demand webinar: An introduction to Maintenance and Reliever Therapy (MART)
Let's be MART for asthma.
Maintenance and Reliever Therapy (MART) asthma action plan
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Maintenance and Reliever Therapy (MART) top tips article
Now is the time to make MART moves for asthma. We have been using the separate blue (reliever) and brown (preventer) inhalers for far too long. The National Review of Asthma Deaths (NRAD) came out a decade ago, yet as a nation, we still have the highest asthma death rate in Europe. This is unsurprising, considering many patients still rely on their blue inhalers alone. However,
You may also be interested in...
Become part of the UK's largest network of dedicated respiratory professionals working in primary, community and integrated care settings.
As a busy healthcare professional, your own professional development can be the last thing on your mind when you are trying to deliver high quality care to your patients as well as dealing with all the everyday matters of working in primary and community care. However, it is the responsibility of every healthcare professional to ensure that they are trained appropriately to be able to deliver the management and care they are required to perform.